Dr Lal PathLabs’ shares sank over four percent intraday on Monday, April 28. While the medical diagnostic centre reported a steady March quarter, brokerages had a mixed outlook for the current quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback